Intra-operative Identification of Parathyroid by Near-infrared Fluorescence System

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000030025

Enrollment

Unknown

Registered

2020-02-20

Start date

2020-02-24

Completion date

Unknown

Last updated

2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid and parathyroid tumor

Interventions

Gold Standard:Pathological examination and parathyroid hormone value of washout fluid from fine needle biopsy.

Index test:Near-infrared&#32

fluorescence&#32

system

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients 18-75 years of age; 2. Who are undergoing thyroid and parathyroid surgery.

Exclusion criteria

Exclusion criteria: Patients with a history of neck trauma, surgery or neck radiotherapy.

Design outcomes

Primary

Measure	Time frame
Fluorescence intensity;SEN, SPE, ACC, AUC of ROC;	—

Secondary

Measure	Time frame
Parathyroid hormone value;Blood calcium;	—

Countries

China

Contacts

Public ContactDetao Yin

The First Affiliated Hospital of Zhengzhou University

detaoyin@zzu.edu.cn+86 13693717963

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026